Polish attitude towards H1N1 pandemic and WHO’s credibility in the context of bioterrorist threats
PDF (English)

Słowa kluczowe

NATIONAL AND INTERNATIONAL SECURITY
BIOTERRORISM
INTERNATIONAL POLITICS

Jak cytować

Milczanowski, M. (2012). Polish attitude towards H1N1 pandemic and WHO’s credibility in the context of bioterrorist threats. Studia Europaea Gnesnensia, (6), 108–121. Pobrano z https://pressto.amu.edu.pl/index.php/seg/article/view/2547

Abstrakt

The article discusses the credibility of WHO, one of the most important global organisations responsible for distributing information, issuing guidelines and recommendations in the case of imminent threat of epidemics, pandemics of bioterrorist attack.  In view of the uniqe character of bioterrorist threat, it is particularly important that such an organisation be beyond any suspicion. Unfortunately, the H1N1 case of 2009 – 2010 caused a tremedous credibility deficit, both among the people and in governments.  European Commission conducted an investigation concerning the justifiability of purchasing drugs that were to halt the pandemics. Yet the most important discovery was that many advisors to government members at the time had connections with pharmaceutical companies, which had a direct influence on state decisions to make bulk purchases of medicines.  On multiple occasions, WHO recommended buying vaccines and administering them to entire populations. In view of all these circumstances, WHO’s credibility has much decreased after the H1N1 crisis. In this situation, the stance of the government ofPoland, which firmly opposed the pressure to buy the vaccines deserves a detailed analysis. It seems that the decision was dictated not only by financial considerations but most of all resulted from a rational assessment of the situation. At the same time, WHO should change the procedure it employs in such situation, becoming a body which does not only advise but also takes responsibility for the recommended solutions.

PDF (English)

Bibliografia

Ashraf H., The Phillips Report on BSE and vCJD, The Lancet 356, 2000, p. 1579–1580.

Cassoobhoy M., S.F. Wetterhall, D.F. Collins, P.T. Cantey, Development of an Interactive Bioterrorism and Emerging Infections Curriculum for Medical Students and Internal Medicine Residents, Public Health Report, 120, 2005, p. 60.

Cohen D., Conflicts of Interest, WHO and the pandemic flu “conspiracies”, BMC (British Medical Association) 2010; 340:c2912.

Cohen H.W., R.M. Gould, V.W. Sidel, Bioterrorism “Preparedness”: Dual Use or Poor Excuse? Public Health Reports, 9–10.2000 (vol. I 15).

Dorosh S., Panic in Ukraine over swine flu BBC Ukrainian Service, Kiev, 3 November 2009, http://news.bbc.co.uk/2/hi/8338835.stm. Accessed April 20, 2011.

Engdahl W., WHO ‘Swine Flu Pope’ under investigation for gross conflict of interest, December 8, 2009. http://www.oilgeopolitics.net/Swine_Flu/Flu_Pope/fl u_pope.html.

Flynn P., The handling of the H1N1 pandemic: more transparency needed, Social Health and Family Aff airs Committee Report, 04.06.2010, in paragraph A, draft resolution 2. http://assembly.coe.int/CommitteeDocs/2010/20100604_H1N1pandemic_e.pdf.

Fox M., Swine flu death rate similar to seasonal flu: expert, Health and Science Editor, Reuters Washington 16.09.2009. http://www.reuters.com/article/2009/09/16/us-fl u-deathsidUSTRE58E6NZ20090916.

Gera V., Poland Refuses Swine Flu Vaccine, Drug Discovery & Development, January 18, 2010.

Johnson Avery E., , S. Kim, Anticipating or Precipitating Crisis? Health Agencies May Not Be Heeding Best Practice Advice in Avian Flu Press Releases, Journal of Public Relations Research 21(2), 2009, p. 187–197.

Kahn L.H., Who’s in Charge? Leadership during Epidemics, Bioterror Attacks, and other Public Health Crises, Santa Barbara, Denver, Oxford 2009, p. 90–91.

Olik M., Poland and the H1N1 Flu: Calm and Unvaccinated, A/H1N1 in Poland, Global Research, November 15, 2009. http://www.globalresearch.ca/.

Orton S., K. Umble, M.V. Davis, J.E. Porter, Disasters and Bioterrorism: does management training develop readiness?, Public Health Reports 6, Nov.–Dec. 2002, p. 596–598.

PACE Health Committee denounces ‘unjustified scare’ of Swine Flu, waste of public money, Press release 455(2010) Strasbourg, June 04, 2010.

Poland praised for anti-swine flu strategy, The news.pl from March 31, 2010. http://www.beyondconformity.co.nz/_literature_85235/Infl uenza_Poland_no_vaccine.

Polish economics, The Washington Times, April 23, 2009.

Ramesh R., Report condemns swine flu experts’ ties to big pharma, The Guardian, June 04, 2010.

Sciolino E., Anthrax vaccination program is failing, Pentagon admits, New York Times, July 13, 2000;

Watson R., Council of Europe launches investigation into H1N1 pandemic BMJ (British Medical Association) 2010; 340:c641.

Weekly epidemiological record Relevé épidémiologique hebdomadaire, 4 december 2009, 84th year / 4 décembre 2009, 84e année. 49, 2009, 84, p. 505–516.

WHO rejects Council of Europe H1N1 accusations, 26.01.2011; http://www.euronews.net.

WHO use of advisory bodies in responding to the influenza pandemic, Pandemic (H1N1) 2009 briefing note 19, 03.12.2009; http://www.who.int/csr/disease/swineflu/notes/briefing_20091203/en/index.html.